Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/12/2026

1. SKHY
2. USO
3. SPY
4. META
5. DAL
6. PEP
7. ALP
8. SKHYV
9. NVDA
10. NRIX

Go back to Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized
AGENUS (NASDAQ: AGEN) Delayed: 3.35 +0.11 (3.40%)
Previous Close $3.24    52 Week High $7.49 
Open $3.24    52 Week Low $2.61 
Day High $3.39    P/E N/A 
Day Low $3.10    EPS $-1.10 
Volume 833,400